Literature DB >> 23426679

Spontaneous optic nerve compression in the osteopetrotic (op/op) mouse: a novel model of myelination failure.

Yoichi Kondo1, Jenna M Ramaker, Abigail B Radcliff, Simona Baldassari, Joshua A Mayer, James N Ver Hoeve, Chuan-Li Zhang, Shing-Yan Chiu, Raymond J Colello, Ian D Duncan.   

Abstract

We report a focal disturbance in myelination of the optic nerve in the osteopetrotic (op/op) mouse, which results from a spontaneous compression of the nerve resulting from stenosis of the optic canal. The growth of the op/op optic nerve was significantly affected, being maximally suppressed at postnatal day 30 (P30; 33% of age matched control). Myelination of the nerve in the optic canal was significantly delayed at P15, and myelin was almost completely absent at P30. The size of nerves and myelination were conserved both in the intracranial and intraorbital segments at P30, suggesting that the axons in the compressed site are spared in all animals at P30. Interestingly, we observed recovery both in the nerve size and the density of myelinated axons at 7 months in almost half of the optic nerves examined, although some nerves lost axons and became atrophic. In vivo and ex vivo electrophysiological examinations of P30 op/op mice showed that nerve conduction was significantly delayed but not blocked with partial recovery in some mice by 7 months. Transcardial perfusion of FITC-labeled albumin suggested that local ischemia was at least in part the cause of this myelination failure. These results suggest that the primary abnormality is dysmyelination of the optic nerve in early development. This noninvasive model system will be a valuable tool to study the effects of nerve compression on the function and survival of oligodendrocyte progenitor cells/oligodendrocytes and axons and to explore the mechanism of redistribution of oligodendrocyte progenitor cells with compensatory myelination.

Entities:  

Mesh:

Year:  2013        PMID: 23426679      PMCID: PMC3677540          DOI: 10.1523/JNEUROSCI.4849-12.2013

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  39 in total

Review 1.  Electrophysiological assessment of optic nerve disease.

Authors:  G E Holder
Journal:  Eye (Lond)       Date:  2004-11       Impact factor: 3.775

Review 2.  The yin and yang of microglia.

Authors:  Melinda Czeh; Pierre Gressens; Angela M Kaindl
Journal:  Dev Neurosci       Date:  2011-07-15       Impact factor: 2.984

Review 3.  Control of oligodendrocyte number in the developing rat optic nerve.

Authors:  B A Barres; M C Raff
Journal:  Neuron       Date:  1994-05       Impact factor: 17.173

Review 4.  Neurological aspects of osteopetrosis.

Authors:  C G Steward
Journal:  Neuropathol Appl Neurobiol       Date:  2003-04       Impact factor: 8.090

5.  Osteopetrosis, a new recessive skeletal mutation on chromosome 12 of the mouse.

Authors:  S C Marks; P W Lane
Journal:  J Hered       Date:  1976 Jan-Feb       Impact factor: 2.645

6.  Galactocerebrosidase-deficient oligodendrocytes maintain stable central myelin by exogenous replacement of the missing enzyme in mice.

Authors:  Yoichi Kondo; David A Wenger; Vittorio Gallo; Ian D Duncan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-13       Impact factor: 11.205

7.  Early VEP and ERG evidence of visual dysfunction in autosomal recessive osteopetrosis.

Authors:  D A Thompson; A Kriss; D Taylor; I Russell-Eggitt; P Hodgkins; G Morgan; A Vellodi; E J Gerritsen
Journal:  Neuropediatrics       Date:  1998-06       Impact factor: 1.947

8.  Pattern of myelination and distribution of neuroglial cells along the developing optic system of the rat and rabbit.

Authors:  R P Skoff; D Toland; E Nast
Journal:  J Comp Neurol       Date:  1980-05-15       Impact factor: 3.215

9.  CSF-1 deficiency in mice results in abnormal brain development.

Authors:  M D Michaelson; P L Bieri; M F Mehler; H Xu; J C Arezzo; J W Pollard; J A Kessler
Journal:  Development       Date:  1996-09       Impact factor: 6.868

10.  Multiple extracellular signals are required for long-term oligodendrocyte survival.

Authors:  B A Barres; R Schmid; M Sendnter; M C Raff
Journal:  Development       Date:  1993-05       Impact factor: 6.868

View more
  4 in total

1.  Amelioration of visual deficits and visual system pathology after mild TBI with the cannabinoid type-2 receptor inverse agonist SMM-189.

Authors:  Natalie M Guley; Nobel A Del Mar; Tyler Ragsdale; Chunyan Li; Aaron M Perry; Bob M Moore; Marcia G Honig; Anton Reiner
Journal:  Exp Eye Res       Date:  2019-03-26       Impact factor: 3.467

Review 2.  Regulation of Embryonic and Postnatal Development by the CSF-1 Receptor.

Authors:  Violeta Chitu; E Richard Stanley
Journal:  Curr Top Dev Biol       Date:  2016-12-01       Impact factor: 4.897

3.  Failed remyelination of the nonhuman primate optic nerve leads to axon degeneration, retinal damages, and visual dysfunction.

Authors:  Nadège Sarrazin; Estelle Chavret-Reculon; Corinne Bachelin; Mehdi Felfli; Rafik Arab; Sophie Gilardeau; Elena Brazhnikova; Elisabeth Dubus; Lydia Yaha-Cherif; Jean Lorenceau; Serge Picaud; Serge Rosolen; Pierre Moissonnier; Pierre Pouget; Anne Baron-Van Evercooren
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-02       Impact factor: 12.779

Review 4.  Ostm1 from Mouse to Human: Insights into Osteoclast Maturation.

Authors:  Jean Vacher; Michael Bruccoleri; Monica Pata
Journal:  Int J Mol Sci       Date:  2020-08-05       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.